申请人:Takeda Chemical Co., Ltd.
公开号:US04074057A1
公开(公告)日:1978-02-14
Compounds of the formula: ##STR1## wherein R.sup.1 represents hydrogen, lower alkyl having 1 to 5 carbon atoms, halogen, hydroxyl, lower alkoxy having 1 to 4 carbon atoms or trifluoromethyl; R.sup.2 and R.sup.3 are the same or different and each represents hydrogen or a lower alkyl having 1 to 5 carbon atoms; Y represents an alkylenethio group having 1 to 6 carbon atoms, alkyleneoxy having 1 to 6 carbon atoms, or alkylenedioxy having 1 to 6 carbon atoms; Z represents a carboxyl group or a group convertible to carboxyl and n is 1 or 2. The compounds have utility in treatment of hyperlipemia and diabetes.
化合物的化学式为:##STR1## 其中R.sup.1代表氢,具有1至5个碳原子的低烷基,卤素,羟基,具有1至4个碳原子的低烷氧基或三氟甲基;R.sup.2和R.sup.3相同或不同,分别代表氢或具有1至5个碳原子的低烷基;Y代表具有1至6个碳原子的烷基硫基,具有1至6个碳原子的烷基氧基或具有1至6个碳原子的烷基二氧基;Z代表羧基或可转化为羧基的基团,n为1或2。该化合物在治疗高脂血症和糖尿病方面具有用途。